HEMEOXYGENASE-1 EXPRESSION AND ROLE IN THYROID CANCER

ALONSO, E.G.; PICHEL, P.; MASCARÓ, M.; SCHWEITZER, K.; FERNÁNDEZ CHÁVEZ, L.; COLÓ, G.P.; PICARDI, G.; RECIO, S.; CARBALLIDO, J.A.; ÁREBALO, J.; CASTELLANO, L.; FACCHINETTI, M.M.; GANDINI, N.A.; CURINO, A.C.

Mar del Plata

Congreso; Reunión anual de sociedades de biociencia; 2019

Thyroid cancer (TC) is the most common worldwide endocrine tumor. Hemeoxygenase-1 (HO-1) is a microsomal enzyme that catalyzes the degradation of the heme group. Our laboratory, among others, has shown that HO-1 is related to tumor progression. The aim of this work was to study the expression and role of HO-1 in TC. In silico studies showed overexpression of HO-1 in papillary (p